How Liver Cirrhosis Causes Black Tarry Stool
Liver cirrhosis causes black tarry stool (melena) primarily through upper gastrointestinal bleeding from portal hypertension-related complications, most commonly esophageal or gastric varices, portal hypertensive gastropathy, and less frequently from portal hypertensive enteropathy.
Pathophysiological Mechanism
The connection between cirrhosis and melena follows this pathway:
Portal Hypertension Development
Cirrhosis increases intrahepatic resistance through two mechanisms 1:
- Structural component (70%): Fibrous tissue, vascular distortion from regenerative nodules, and microthrombi
- Functional component (30%): Increased intrahepatic vascular tone from endothelial dysfunction
This elevated portal pressure leads to formation of portosystemic collaterals (varices) and splanchnic vasodilation, which further increases portal venous inflow 1.
Bleeding Sources
Variceal hemorrhage is the most dramatic cause:
- Esophageal and gastric varices develop as collateral vessels
- These thin-walled vessels rupture under high pressure
- Blood passes through the GI tract, becoming oxidized and digested, turning black and tarry 2, 3
Portal hypertensive gastropathy is another common source 4:
- Identified in 2-12% of cirrhotic patients presenting with GI bleeding
- Can cause both acute bleeding and chronic blood loss
- Increased fibrinolysis also contributes to bleeding tendency 4
Less common sources include:
- Portal hypertensive enteropathy (small bowel varices) 4, 5
- Portal hypertensive colopathy
- Duodenal varices 6
Clinical Presentation
The black tarry appearance (melena) occurs because:
- Blood originates from upper GI tract (above ligament of Treitz)
- Hemoglobin is oxidized by gastric acid and digestive enzymes
- This produces hematin, which appears black
- Transit time allows complete digestion, creating the characteristic tarry consistency
Important caveat: Hematemesis (vomiting blood) at presentation indicates more severe bleeding and worse outcomes compared to melena alone, with significantly higher 5-day rebleeding rates (19.0% vs 10.6%) and in-hospital mortality (8.4% vs 2.8%) 3.
Management Approach
When cirrhotic patients present with melena 4:
For portal hypertension-related bleeding:
- Vasoactive therapy (acute setting) to reduce portal pressure
- Endoscopic intervention for varices
- Beta-blockers for chronic management
- TIPS placement for refractory cases
For non-portal hypertensive causes:
- Local endoscopic measures first
- Address contributing factors (renal failure, infection, anemia)
- Correction of coagulopathy only on case-by-case basis 4
Critical pitfall: Not all GI bleeding in cirrhosis is from varices. Acute esophageal necrosis, peptic ulcers, and other non-portal hypertensive sources must be considered, particularly with hemodynamic instability 2.